19-57473600-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001144068.2(ZNF772):c.1021G>A(p.Glu341Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,613,976 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144068.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF772 | NM_001144068.2 | c.1021G>A | p.Glu341Lys | missense_variant | 4/4 | ENST00000356584.8 | NP_001137540.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF772 | ENST00000356584.8 | c.1021G>A | p.Glu341Lys | missense_variant | 4/4 | 2 | NM_001144068.2 | ENSP00000348992.3 | ||
ENSG00000268163 | ENST00000596831.1 | c.199+2060G>A | intron_variant | 2 | ENSP00000470969.1 |
Frequencies
GnomAD3 genomes AF: 0.000842 AC: 128AN: 151988Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000680 AC: 171AN: 251460Hom.: 1 AF XY: 0.000773 AC XY: 105AN XY: 135908
GnomAD4 exome AF: 0.00113 AC: 1650AN: 1461868Hom.: 1 Cov.: 41 AF XY: 0.00112 AC XY: 813AN XY: 727224
GnomAD4 genome AF: 0.000842 AC: 128AN: 152108Hom.: 1 Cov.: 33 AF XY: 0.000955 AC XY: 71AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1144G>A (p.E382K) alteration is located in exon 5 (coding exon 5) of the ZNF772 gene. This alteration results from a G to A substitution at nucleotide position 1144, causing the glutamic acid (E) at amino acid position 382 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at